Publications by authors named "M Birgitte Visch"
Psoriasis healthcare during the COVID-19 pandemic: a survey among psoriasis patients (PsoCovidCare).
J Dermatolog Treat
December 2024
Background: During the COVID-19 pandemic, psoriasis care underwent significant changes in consultation methods and treatment management. However, comprehensive data on these changes and patient perceptions are limited.
Aims: To evaluate the pandemic's implications on psoriasis patients, focusing on access to information, consultation methods, patient satisfaction, disease control assessment, and treatment management changes.
Article Synopsis
- The study examines the risk of SARS-CoV-2 infection in psoriasis patients undergoing different treatments, specifically comparing biologics, systemic conventional therapies, and topical therapies.
- Among 551 patients, only 10.7% were found to have had a SARS-CoV-2 infection, with no significant increase in infection risk for those using biologics.
- The results showed a low hospitalization rate (0.7%) and a mortality rate of 0.32% across all treatment groups, indicating that psoriasis treatment does not significantly affect COVID-19 severity.
Optimal selection of systemic therapy in older adults with psoriasis can be challenging, due to sparse evidence-based guidance. This multicentre retrospective study investigated the safety of systemic therapy with causality assessment in a real-world cohort of older adults (≥ 65 years) with psoriasis. Data from 6 hospitals on (serious) adverse events were collected, causality assessment performed and incidence rate ratios calculated.
View Article and Find Full Text PDFBackground: Psoriasis is a common inflammatory disease in any age group, but also in older patients (≥ 65 years of age). Since older patients are often excluded from clinical trials, limited data specifically on this growing population are available, e.g.
View Article and Find Full Text PDF